Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo

References

1. Alamillo J. M., Monger W., Sola I., Garcia B., Perrin Y., Bestagno M., Burrone O. R., Sabella P., Plana-Duran J. other authors 2006; Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodies. Biotechnol J 1:1103–1111 [CrossRef]
   [Google Scholar]
2. Batista F. D., Efremov D. G., Burrone O. R. 1996; Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly. Proc Natl Acad Sci U S A 93:3399–3404 [CrossRef]
   [Google Scholar]
3. Borsi L., Balza E., Bestagno M., Castellani P., Carnemolla B., Biro A., Leprini A., Sepulveda. J., Burrone O. other authors 2002; Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102:75–85 [CrossRef]
   [Google Scholar]
4. Castilla J., Pintado B., Sola I., Sánchez-Morgado J. M., Enjuanes L. 1998; Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk. Nat Biotechnol 16:349–354 [CrossRef]
   [Google Scholar]
5. Correa I., Jiménez G., Suñé C., Bullido M. J., Enjuanes L. 1988; Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus Res 10:77–93 [CrossRef]
   [Google Scholar]
6. Correa I., Gebauer F., Bullido M. J., Suñé C., Baay M. F., Zwaagstra K. A., Posthumus W. P. A., Lenstra J. A., Enjuanes L. 1990; Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J Gen Virol 71:271–279 [CrossRef]
   [Google Scholar]
7. Delmas B., Gelfi J., L'Haridon R., Vogel L. K., Sjöström H., Noren O., Laude H. 1992; Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357:417–420 [CrossRef]
   [Google Scholar]
8. Delmas B., Kut E., Gelfi J., Laude H. 1995; Overexpression of TGEV cell receptor impairs the production of virus particles. Adv Exp Med Biol 380:379–385
   [Google Scholar]
9. Enjuanes L., Van der Zeijst B. A. M. 1995; Molecular basis of transmissible gastroenteritis virus epidemiology. In The Coronaviridae pp  337–376 Edited by Siddell S. G. New York: Plenum Press;
   [Google Scholar]
10. Escors D., Camafeita E., Ortego J., Laude H., Enjuanes L. 2001; Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol 75:12228–12240 [CrossRef]
    [Google Scholar]
11. Gebauer F., Posthumus W. P. A., Correa I., Suñé C., Smerdou C., Sánchez C. M., Lenstra J. A., Meloen R. H., Enjuanes L. 1991; Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology 183:225–238 [CrossRef]
    [Google Scholar]
12. Hu S., Shively L., Raubitschek A., Sherman M., Williams L. E., Wong J. Y., Shively J. E., Wu A. M. 1996; Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 56:3055–3061
    [Google Scholar]
13. Jiménez G., Correa I., Melgosa M. P., Bullido M. J., Enjuanes L. 1986; Critical epitopes in transmissible gastroenteritis virus neutralization. J Virol 60:131–139
    [Google Scholar]
14. Li E., Pedraza A., Bestagno M., Mancardi S., Sanchez R., Burrone O. 1997; Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng 10:731–736 [CrossRef]
    [Google Scholar]
15. Monger W., Alamillo J. M., Sola I., Perrin Y., Bestagno M., Burrone O. R., Sabella P., Plana-Duran J., Enjuanes L. other authors 2006; An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts. Plant Biotechnol J 4:623–631 [CrossRef]
    [Google Scholar]
16. Occhino M., Raffaghello L., Burrone O., Gambini C., Pistoia V., Corrias M. V., Bestagno M. 2004; Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2. Int J Mol Med 14:383–388
    [Google Scholar]
17. Pack P., Müller K., Zahn R., Plückthun A. 1995; Tetravalent miniantibodies with high avidity assembling in Escherichia coli . J Mol Biol 246:28–34 [CrossRef]
    [Google Scholar]
18. Sánchez C. M., Jiménez G., Laviada M. D., Correa I., Suñé C., Bullido M., Gebauer F., Smerdou C., Callebaut P. other authors 1990; Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 174:410–417 [CrossRef]
    [Google Scholar]
19. Sánchez C. M., Gebauer F., Suñé C., Méndez A., Dopazo J., Enjuanes L. 1992; Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 190:92–105 [CrossRef]
    [Google Scholar]
20. Sánchez C. M., Izeta A., Sánchez-Morgado J. M., Alonso S., Sola I., Balasch M., Plana-Duran J., Enjuanes L. 1999; Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J Virol 73:7607–7618
    [Google Scholar]
21. Sola I., Castilla J., Pintado B., Sánchez-Morgado J. M., Whitelaw C. B., Clark A. J., Enjuanes L. 1998; Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virol 72:3762–3772
    [Google Scholar]
22. Suñé C., Jiménez G., Correa I., Bullido M. J., Gebauer F., Smerdou C., Enjuanes L. 1990; Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 177:559–569 [CrossRef]
    [Google Scholar]
23. Torres J. M., Sánchez C., Suñé C., Smerdou C., Prevec L., Graham F., Enjuanes L. 1995; Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213:503–516 [CrossRef]
    [Google Scholar]
24. Winter G., Milstein C. 1991; Man-made antibodies. Nature 349:293–299 [CrossRef]
    [Google Scholar]